GlassScriptPhysician profile
James M Yau
NPI 1467654764
$3,248.51
in general payments reported to CMS, 2019-2025
35 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $81.05 · 2021: $494 · 2022: $408 · 2023: $651 · 2024: $692 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $493.45 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $333.16 | 2020-2025 | Lifevest |
| Abiomed | $288.23 | 2022-2025 | Impella |
| Abbott Laboratories | $272.51 | 2021-2023 | Xience Skypoint, Jeti Peripheral Catheter, Nc Trek Neo |
| Pfizer INC. | $266.88 | 2021-2025 | |
| Heartflow, INC. | $229.17 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $180.24 | 2021-2025 | Camzyos, Eliquis |
| Philips North America LLC | $162.66 | 2024-2025 | (Ck4) Mcot, (Ck7) Extended Holter, Extended Holter |
| Chiesi USA, INC. | $108.52 | 2020-2021 | |
| Novo Nordisk INC | $91.68 | 2021-2024 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.95 | 2019-2025 | Jardiance |
| Inspire Medical Systems, INC. | $64.58 | 2023-2024 | Inspire |
| Merck Sharp & Dohme LLC | $60.50 | 2024-2025 | Verquvo |
| Amgen INC. | $59.23 | 2019 | |
| Shockwave Medical, INC | $57.12 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $53.91 | 2021-2024 | In.Pact Admiral |
| Janssen Pharmaceuticals, INC | $50.49 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $45.30 | 2023 | Inpefa |
| Silk Road Medical, INC. | $42.82 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Baxter Healthcare | $36.83 | 2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $34.98 | 2019-2024 | Farxiga |
| Angiodynamics, INC. | $26.80 | 2021-2022 | |
| Becton, Dickinson and Company | $24.69 | 2024 | Site-Rite |
| Atricure, INC. | $21.65 | 2023 | |
| Koya Medical, INC. | $20.22 | 2025 | Koya Medical, Dayspring |
| Irhythm Technologies, INC. | $19.26 | 2020 | |
| Lantheus Medical Imaging, INC. | $18.48 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.01 | 2021 | |
| Cleerly, INC. | $15.74 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Gilead Sciences, INC. | $15.73 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.61 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $12.52 | 2021 | |
| Medtronic Vascular, INC. | $11.94 | 2019 | |
| Edwards Lifesciences Corporation | $11.90 | 2019 | |
| Portola Pharmaceuticals, LLC | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Yau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.